Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03149822
Brief Title: Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma

First Submitted : April 28, 2017
First Submitted that Met QC Criteria : May 10, 2017
First Posted : May 11, 2017

Last Update Submitted that Met QC Criteria : March 19, 2021
Last Update Posted : March 23, 2021